The Mechanism of Co-Receptor Regulation of B-cell Activation
B 细胞激活的共受体调节机制
基本信息
- 批准号:8745432
- 负责人:
- 金额:$ 62.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AffinityAntibodiesAntibody FormationAntigen-Antibody ComplexAntigensAttentionAutoimmune DiseasesAutoimmunityB-Cell ActivationB-Cell NeoplasmB-LymphocytesBindingCD19 geneCoinCollaborationsComplementComplement 3d ReceptorsComplexCoupledCytoplasmic TailDimerizationEnvironmentEventFc ReceptorFluorescence Resonance Energy TransferHumanImageImaging technologyImmune responseImmunoglobulin GImmunoglobulin MImmunologic MemoryLifeLipidsMediatingMembraneMembrane MicrodomainsMemoryMemory B-LymphocyteMicroscopicMicroscopyMolecularPathway interactionsPhosphotransferasesPlayProcessRecruitment ActivityRegulationResolutionRestRoleSignal PathwaySignal TransductionSpatial Distributionantigen bindingcellular imagingkillingsmolecular sizereceptorresponsesingle moleculespatial relationship
项目摘要
The B cell response to antigen is regulated by a variety of co-receptors that convey information to the B cell about the quality of the antigen and the status of the ongoing immune response. Our progress using high resolution live cell imaging to delineate the very early antigen driven events in B cell activation has provided a new context in which the impact of coreceptors can be evaluated. Using high resolution fluorescence resonance energy transfer (FRET) coupled with total internal reflection microscopy (TIRFM) and single molecule tracking we provided evidence for an ordered process that occurs within seconds to minutes of the BCR binding antigen. Antigen bound BCRs form immobile clusters that then grow in size by molecular trapping. The clusters perturb the local lipid environment causing lipid rafts to coalesce around the BCR clusters. As a consequence of the membrane perturbation the first kinase in the pathway, Lyn, that is tethered to the membrane by raft lipids is brought into close molecular proximity to the BCR clusters. Simultaneously, Lyn phosphorylates the Ig alpha beta cytoplasmic domain of the BCR and the Ig alpha beta chains undergo a conformational change from a closed to an open form. Syk is recruited to the phosphorylated BCR and the signaling cascades are triggered.
Over the last year we characterized the effect of the inhibitory receptor FcgammaRIIB engagement on the activation of human naive and MBCs. Using high-resolution imaging we showed that human MBCs are more robust than naive B cells at each step in the initiation of BCR signaling, including interrogation of antigen containing membranes, formation of sub-microscopic BCR oligomers and recruitment and activation of signaling-associated kinases. Despite their robust response to antigen, MBCs remain highly sensitive to FcgammaRIIB-mediated inhibition. These observations are important for understanding the regulation of memory antibody responses.
We also demonstrated in human B cells that the rapid accumulation of BCRs at the interface of the B cell on antigen-containing bilayer triggers the independent accumulation of phosphorylated CD19 accompanied by the accumulation and colocalization of phosphorylated PI3K, a key component in the BCR-CD19 signaling pathway. Remarkably, coligation of the BCR and FcgammaRIIB blocked the accumulation of the BCR, and phosphorylated CD19 and PI3K. These results suggest an additional facet of the inhibition of BCR signaling by the FcgammaRIIB. We will continue these studies in collaboration with Dr. Ezio Bonvini and his colleagues at Macrogenics. Dr. Bonvinis group has developed bi-functional antibodies coined DARTS that allow the dimerization of the BCR and CD19 or the BCR and FcgammaRIIB. The BCR-FcgammaRIIB DARTS are showing efficacy in blocking B cell activation in autoimmune disease and killing BCR-dependent B cell tumors. We are exploring the effect of these DARTS on BCR signaling using high resolution live cell imaging.
Over the last year we have made progress in establishing super-high resolution imaging to describe, at the 10-50 nm level, the spatial relationship between the BCR, CD19 and FcgammaRIIB in resting human B cells and in B cells in which the BCR is ligated alone by Ag or Fcgamma is ligated by immune complexes. We are also characterizing the spatial distribution of these receptors on naive human IgM expressing B cells and in IgG-expressing memory B cells.
对抗原的B细胞应答受多种共受体调节,所述共受体向B细胞传递关于抗原的质量和正在进行的免疫应答的状态的信息。 我们使用高分辨率活细胞成像描绘B细胞活化中非常早期的抗原驱动事件的进展提供了一个新的背景,其中可以评估辅助受体的影响。 使用高分辨率荧光共振能量转移(FRET)结合全内反射显微镜(TIRFM)和单分子跟踪,我们提供了证据,在BCR结合抗原的数秒至数分钟内发生的有序过程。 抗原结合的BCR形成不动的簇,然后通过分子捕获使其尺寸增大。 这些簇扰乱了局部脂质环境,导致脂筏在BCR簇周围聚结。 作为膜扰动的结果,途径中的第一个激酶林恩通过筏脂质与膜连接,使其分子与BCR簇紧密接近。 同时,林恩使BCR的IG α β胞质结构域磷酸化,并且IG α β链经历从封闭形式到开放形式的构象变化。 Syk被募集到磷酸化的BCR,并触发信号级联反应。
在过去的一年中,我们表征了抑制性受体Fc γ RIIB接合对人幼稚和MBC活化的影响。 使用高分辨率成像,我们表明,人MBCs比幼稚B细胞在BCR信号传导起始的每个步骤,包括询问含抗原的膜,形成亚显微镜下的BCR寡聚体和募集和激活信号传导相关的激酶,更强大。 尽管它们对抗原有强烈的应答,但MBC对Fc γ RIIB介导的抑制仍然高度敏感。 这些观察对于理解记忆抗体反应的调节是重要的。
我们还在人B细胞中证明,BCR在含抗原双层上的B细胞界面处的快速积累触发了磷酸化CD 19的独立积累,同时伴随着磷酸化PI 3 K(BCR-CD 19信号通路中的关键组分)的积累和共定位。值得注意的是,BCR和Fc γ RIIB的共连接阻断了BCR的积累,以及磷酸化的CD19和PI3K。这些结果表明Fc γ RIIB抑制BCR信号传导的另一个方面。我们将继续与Ezio Bonvini博士和他在Macrogenics的同事合作进行这些研究。Bonvinis博士的团队开发了双功能抗体DARTS,允许BCR和CD19或BCR和Fc γ RIIB的二聚化。BCR-Fc γ RIIB DARTS在阻断自身免疫性疾病中的B细胞活化和杀死BCR依赖性B细胞肿瘤方面显示出功效。我们正在使用高分辨率活细胞成像来探索这些DARTS对BCR信号传导的影响。
在过去的一年中,我们在建立超高分辨率成像以在10 - 50 nm水平上描述静息的人B细胞和B细胞中BCR、CD 19和Fc γ RIIB之间的空间关系方面取得了进展,其中BCR通过Ag单独连接或Fc γ通过免疫复合物连接。我们还表征了这些受体在表达幼稚人IgM的B细胞和表达IgG的记忆B细胞上的空间分布。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan Pierce其他文献
Susan Pierce的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan Pierce', 18)}}的其他基金
Intracellular Trafficking Of The B cell Antigen Receptor
B 细胞抗原受体的细胞内运输
- 批准号:
6521528 - 财政年份:
- 资助金额:
$ 62.92万 - 项目类别:
The Mechanism of Co-Receptor Regulation of B-cell Activation
B 细胞激活的共受体调节机制
- 批准号:
8555905 - 财政年份:
- 资助金额:
$ 62.92万 - 项目类别:
B cell Receptor Dysregulation in Cancer and Autoimmune Disease
癌症和自身免疫性疾病中的 B 细胞受体失调
- 批准号:
8745551 - 财政年份:
- 资助金额:
$ 62.92万 - 项目类别:
Intracellular Trafficking and Signaling Of The B-cell Antigen Receptor
B 细胞抗原受体的细胞内运输和信号转导
- 批准号:
8745390 - 财政年份:
- 资助金额:
$ 62.92万 - 项目类别:
The Mechanism of Co-Receptor Regulation of B-cell Activation
B 细胞激活的共受体调节机制
- 批准号:
9566642 - 财政年份:
- 资助金额:
$ 62.92万 - 项目类别:
B cell Receptor Dysregulation in Cancer and Autoimmune Disease
癌症和自身免疫性疾病中的 B 细胞受体失调
- 批准号:
8157106 - 财政年份:
- 资助金额:
$ 62.92万 - 项目类别:
The Mechanism of Co-Receptor Regulation of B-cell Activation
B 细胞激活的共受体调节机制
- 批准号:
8156981 - 财政年份:
- 资助金额:
$ 62.92万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 62.92万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 62.92万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 62.92万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 62.92万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 62.92万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 62.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 62.92万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 62.92万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 62.92万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 62.92万 - 项目类别: